News
-
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
Telomir Pharmaceuticals announces in vitro findings showcasing Telomir-1's dual action targeting DNA methylation switches and the Wnt 'fuel line' driving cancer growth -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
Telomir Pharmaceuticals, Inc. reveals new preclinical data showing Telomir-1's potent inhibition of histone demethylase enzymes implicated in cancer, autoimmune conditions, neurodegeneration, and metabolic disorders -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathways in A
Telomir Pharmaceuticals announces promising preclinical results showing the compound Telomir-1 restores mitochondrial function without triggering oxidative stress or cell proliferation in Progeria human cells -
